VanEck Environmental Services ETF EVX
40.36 USD -0.17 (-0.41%)
Nov 6, 2026, 3:59 PM EST
40.00 Day range 40.37
36.65 52-week range 42.32
- YTD
- +5.57%
- 1 year
- +10.12%
News
globenewswire.com Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting The data further validate the potential of EVX-04 as an off-the-shelf therapeutic vaccine for acute myeloid leukemia Data will be presented in a poster session at the American Society of Hematology…
globenewswire.com Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting New data from the phase 2 trial with EVX-01 to be presented in both an oral and poster session COPENHAGEN, Denmark, November 3, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio…
benzinga.com Ecolab Q3 Earnings: Beats On EPS, Misses On Sales, Revises Annual EPS Forecast & More (CORRECTED) Ecolab reported lower Q3 sales growth of 1%, missing consensus estimate. Organic sales up 4%, operating income up 17%. Revised FY24 outlook.